Get startedLog in
    Picture of U2Bio Co logo

    221800 — U2Bio Co Cashflow Statement

    0.000.00%
    kr flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for U2Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:Annual Audited AccountsARSAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Net Income/Starting Line9,23613,160646-2,840-1,642
    Depreciation
    Amortisation
    Non-Cash Items2743,065-1,031621-58.8
    Unusual Items
    Other Non-Cash Items
    Changes in Working Capital2,6717,293-3,088-389-696
    Change in Accounts Receivable
    Change in Inventories
    Change in Accounts Payable
    Change in Accrued Expenses
    Change in Other Liabilities
    Net Change in Other Assets & Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities12,75124,406-2,555-1,731-1,562
    Capital Expenditures-387-1,142-978-353-201
    Purchase of Fixed Assets
    Purchase / Acquisition of Intangibles
    Other Investing Cash Flow Items-116-35,54434,183-15,979-12,947
    Sale/Maturity of Investment
    Purchase of Investments
    Sale of Intangible Assets
    Other Investing Cash Flow
    Cash from Investing Activities-503-36,68633,205-16,333-13,148
    Financing Cash Flow Items——-326—-20.3
    Other Financing Cash Flow
    Total Cash Dividends Paid
    Net Issuance / Retirement of Stock
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-265-2,7713,207-737-436
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash11,983-15,05233,858-18,801-15,147